473 related articles for article (PubMed ID: 1846412)
1. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
Negus SS; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
[TBL] [Abstract][Full Text] [Related]
4. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
6. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1992 Jan; 260(1):334-42. PubMed ID: 1309877
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
[TBL] [Abstract][Full Text] [Related]
8. Interactions between mu and kappa opioid agonists in the rat drug discrimination procedure.
Negus SS; Picker MJ; Dykstra LA
Psychopharmacology (Berl); 1990; 102(4):465-73. PubMed ID: 1965748
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons.
Picker M; Dykstra LA
J Pharmacol Exp Ther; 1987 Dec; 243(3):938-45. PubMed ID: 3320348
[TBL] [Abstract][Full Text] [Related]
10. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
11. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
[TBL] [Abstract][Full Text] [Related]
12. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
DeRossett SE; Holtzman SG
J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.
Dykstra LA; Massie CA
J Pharmacol Exp Ther; 1988 Sep; 246(3):813-21. PubMed ID: 2843630
[TBL] [Abstract][Full Text] [Related]
15. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids.
Spealman RD; Bergman J
J Pharmacol Exp Ther; 1992 May; 261(2):607-15. PubMed ID: 1315861
[TBL] [Abstract][Full Text] [Related]
17. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys.
Bergman J; Warren PH
J Pharmacol Exp Ther; 1989 Mar; 248(3):1102-8. PubMed ID: 2539457
[TBL] [Abstract][Full Text] [Related]
18. Kappa antagonist properties of buprenorphine in the shock titration procedure.
Negus SS; Dykstra LA
Eur J Pharmacol; 1988 Oct; 156(1):77-86. PubMed ID: 2850212
[TBL] [Abstract][Full Text] [Related]
19. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
Capasso A; Sorrentino L
Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
[TBL] [Abstract][Full Text] [Related]
20. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
Negus SS; Mello NK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]